Cargando…
A single injection of crystallizable fragment domain–modified antibodies elicits durable protection from SHIV infection
In the absence of an effective and safe vaccine against HIV-1, the administration of broadly neutralizing antibodies (bNAbs) represents a logical alternative approach to prevent virus transmission. Here, we introduced two mutations encoding amino acid substitutions (M428L and N434S, collectively ref...
Autores principales: | Gautam, Rajeev, Nishimura, Yoshiaki, Gaughan, Natalie, Gazumyan, Anna, Schoofs, Till, Buckler-White, Alicia, Seaman, Michael S., Swihart, Bruce J., Follmann, Dean A., Nussenzweig, Michel C., Martin, Malcolm A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5989326/ https://www.ncbi.nlm.nih.gov/pubmed/29662199 http://dx.doi.org/10.1038/s41591-018-0001-2 |
Ejemplares similares
-
Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia
por: Nishimura, Yoshiaki, et al.
Publicado: (2020) -
Crystallizable Fragment Glycoengineering for Therapeutic Antibodies Development
por: Li, Wei, et al.
Publicado: (2017) -
Durable protection against repeated penile exposures to simian-human immunodeficiency virus by broadly neutralizing antibodies
por: Garber, David A., et al.
Publicado: (2020) -
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques
por: Shingai, Masashi, et al.
Publicado: (2014) -
Molecular Dynamics Simulation of the Crystallizable Fragment of IgG1—Insights for the Design of Fcabs
por: Lai, Balder, et al.
Publicado: (2014)